| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |